Celltrion
068270.KS
#755
Rank
โ‚น2.348 T
Marketcap
โ‚น10,759
Share price
-1.22%
Change (1 day)
-2.04%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): โ‚น245.26

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น258.77. In 2022 the company made an earnings per share (EPS) of โ‚น251.92 a decrease over its 2021 EPS that were of โ‚น299.34.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น245.26-2.64%
2022โ‚น251.92-15.84%
2021โ‚น299.3412.77%
2020โ‚น265.4470.79%
2019โ‚น155.4215.63%
2018โ‚น134.41-33.13%
2017โ‚น201.01141.17%
2016โ‚น83.358.28%
2015โ‚น76.9811.28%
2014โ‚น69.1816.37%
2013โ‚น59.44-67.42%
2012โ‚น182.4784.22%
2011โ‚น99.0562.13%
2010โ‚น61.1080.61%
2009โ‚น33.83-559.63%
2008-โ‚น7.36-123.16%
2007โ‚น31.78